Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001137050-15-000037
Filing Date
2015-02-17
Accepted
2015-02-13 18:59:39
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 pkph10q20141231ver5.htm 10-Q 339407
2 exh311.htm EX-31 5620
3 exh312.htm EX-31 5609
4 exh321.htm EX-32 2074
5 exh322.htm EX-32 1962
  Complete submission text file 0001137050-15-000037.txt   1950266

Data Files

Seq Description Document Type Size
6 pkph-20141231.xml EX-101.INS 246308
7 pkph-20141231.xsd EX-101.SCH 18799
8 pkph-20141231_lab.xml EX-101.LAB 91950
9 pkph-20141231_pre.xml EX-101.PRE 86476
10 pkph-20141231_cal.xml EX-101.CAL 6355
11 pkph-20141231_def.xml EX-101.DEF 34919
Mailing Address 4450 ARAPAHOE AVENUE SUITE 100 BOULDER CO 80303
Business Address 4450 ARAPAHOE AVENUE SUITE 100 BOULDER CO 80303 303-415-2557
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

EIN.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-53855 | Film No.: 15617166
SIC: 2834 Pharmaceutical Preparations